노을 둜고

노을 (376930) μ£Όκ°€ 및 μ’…λͺ© 정보

노을 μ‹€μ‹œκ°„ μ£Όκ°€

노을 ν˜„μž¬κ°€ 상세 정보
ν•­λͺ© κ°’
ν˜„μž¬κ°€ 1,373 원
λ³€λ™λŸ‰ β–Ό 87.00 원
변동λ₯  -5.96%
κ±°λž˜λŸ‰ 1,578,272
κ±°λž˜λŒ€κΈˆ 2,153,151,764 원

노을 일별 μ£Όκ°€

λ…Έμ„μ˜ κ³Όκ±° 일별 μ£Όκ°€
λ‚ μ§œ μ‹œκ°€ κ³ κ°€ μ €κ°€ μ’…κ°€ κ±°λž˜λŸ‰ κ±°λž˜λŒ€κΈˆ
4/20/2026 1,760 1,770 1,689 1,707 369,719 630,657,869
4/21/2026 1,706 1,730 1,680 1,703 214,775 365,069,833
4/22/2026 1,700 1,718 1,675 1,689 243,974 411,722,223
4/23/2026 1,702 1,709 1,680 1,685 211,602 357,874,199
4/26/2026 1,700 1,735 1,681 1,728 634,994 1,062,922,083
4/27/2026 1,714 1,728 1,680 1,682 310,396 524,781,421
4/28/2026 1,682 1,696 1,652 1,654 268,436 447,504,294
4/29/2026 1,670 1,679 1,543 1,548 767,313 1,217,006,555
5/3/2026 1,551 1,580 1,450 1,460 1,022,788 1,521,003,520
5/5/2026 1,460 1,508 1,310 1,373 1,578,272 2,153,151,764

κ΄€λ ¨ ν…Œλ§ˆ

  • ν•œλ™ν›ˆ : λ…Έμ„μ˜ 이선지 사외이사가 ν•œλ™ν›ˆ μž₯κ΄€κ³Ό λ²•λŒ€ λ™λ¬Έμ΄μž μ½œλŸΌλΉ„μ•„ λŒ€ν•™ λ™λ¬Έμ΄λΌλŠ” 점이 μ•Œλ €μ§€λ©΄μ„œ κ΄€λ ¨μ£Όλ‘œ 뢀각됨

노을 νšŒμ‚¬ 정보

μ‹œμž₯ μ‹œκ°€μ΄μ•‘ κΈ°μ—…μˆœμœ„ μ£Όμ‹μˆ˜ 외ꡭ인 비쀑 μ‚°μ—…κ΅° μ„ΈλΆ€ μ‚°μ—…κ΅° 52μ£Ό 졜고 52μ£Ό μ΅œμ €
kosdaq 704μ–΅ 1112μœ„ 51,291,323 7.43% ν—¬μŠ€μΌ€μ–΄ 의료μž₯λΉ„/μš©ν’ˆ 3,880 1,418

노을 κΈ°μ—… κ°œμš”

노을은 2015λ…„ 12μ›” 04일 μ„€λ¦½λœ κΈ°μ—…μœΌλ‘œ 전기식 진단 및 μš”λ²• κΈ°κΈ° μ œμ‘°μ—…μ„ μ£Όμš” μ‚¬μ—…μœΌλ‘œ μ˜μœ„ν•˜κ³  μžˆλ‹€. μ£Όμš” λ§€μΆœμ€ ν˜ˆμ•‘κ²€μ‚¬ 진단기기 μ œν’ˆ νŒλ§€μ—μ„œ λ°œμƒν•˜κ³  μžˆλ‹€. λ‹Ήμ‚¬λŠ” μƒ˜ν”Œ ν”„λ ™λΆ€ν„° AIκ²°κ³Ό νŒλ…κΉŒμ§€ ν˜„λ―Έκ²½ μ§„λ‹¨μ˜ 전과정을 μžλ™ν™”ν•œ 세계 유일의 νƒˆμ€‘μ•™ν™” 진단 ν”Œλž«νΌ κΈ°μ—…μœΌλ‘œ 말라리아 진단, ν˜ˆκ΅¬ν˜•νƒœλΆ„μ„, μžκΆκ²½λΆ€μ•” 검사 μ œν’ˆμ„ μΆœμ‹œν•˜μ˜€κ³  이어 μœ λ°©μ•”, 갑상선암 λ“±μ˜ μΉ΄νŠΈλ¦¬μ§€ κ°œλ°œμ— μ§‘μ€‘ν•˜κ³  μžˆλ‹€.

노을 AI예츑

AIμ˜ˆμΈ‘κΈ°λŠ” 노을을 κ°•λ ₯맀도 Β· 맀도 Β· 쀑립 Β· 맀수 Β· κ°•λ ₯맀수 둜 μ˜ˆμΈ‘ν–ˆμ–΄μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ μ˜ˆμƒ μ£Όκ°€ μ‹œλ‚˜λ¦¬μ˜€μ™€ AI의 투자의견, λͺ©ν‘œΒ·μ†μ ˆκ°€, AIκ°€ μ°Έκ³ ν•œ 차트 νŒ¨ν„΄λ“€μ„ 확인할 수 μžˆμŠ΅λ‹ˆλ‹€.

노을 μ§€ν‘œλΆ„μ„

수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ€ 노을을 맀수 Β· 맀도 Β· 보유 Β· 관망 μ€‘μ΄μ—μš”.

멀버십 ν”Œλžœμ„ κ΅¬λ…ν•˜λ©΄ 수읡λ₯  1μœ„ λ§€λ§€μ „λž΅μ˜ 맀맀 μ‹œμ μ„ ν™•μΈν•˜κ³  λ‹€μŒ μ‹ ν˜Έλ₯Ό μ•Œλ¦ΌμœΌλ‘œ λ°›μ•„λ³Ό 수 μžˆμŠ΅λ‹ˆλ‹€.

μ΅œμ‹  노을 κ΄€λ ¨ λ‰΄μŠ€

노을(λŒ€ν‘œ μž„μ°¬μ–‘)은 의료기기 μ „λ¬Έ μœ ν†΅μ—…μ²΄μ™€ μΊλ¦¬λΉ„μ•ˆ μ‹œμž₯을 λŒ€μƒμœΌλ‘œ μžμ‚¬μ˜ AI 진단 ν”Œλž«νΌ β€˜miLabℒ’을 κ³΅κΈ‰ν•˜λŠ” 계약을 μ²΄κ²°ν–ˆλ‹€κ³  λ°ν˜”λ‹€.이번 계약에 따라 노을은 AI 기반 말라리아 진단 μ†”λ£¨μ…˜(MAL), ν˜ˆμ•‘ 뢄석 μ†”λ£¨μ…˜(BCM), μžκΆκ²½λΆ€μ•” 진단 μ†”λ£¨μ…˜(CER) λ“± μ „ μ œν’ˆκ΅°μ„ μΊλ¦¬λΉ„μ•ˆ 지역에 곡급할 μ˜ˆμ •μ΄λ‹€. μ΄λŠ” 노을이 μ§€μ†μ μœΌλ‘œ μΆ”μ§„ν•΄μ˜¨ 쀑남미(LATAM) μ‹œμž₯ ν™•λŒ€ μ „λž΅μ˜ μΌν™˜μœΌλ‘œ, μΊλ¦¬λΉ„μ•ˆ 지역 μ‹œμž₯ μ§„μΆœμ˜ ꡐ두보λ₯Ό λ§ˆλ ¨ν•˜κ³  miLab의 강점인 ν˜„μž₯ 진단 기반으둜 의료 μ ‘κ·Όμ„±

노을이 μ§€λ‚œν•΄ 200얡원 μ΄μƒμ˜ μ˜μ—…μ μžλ₯Ό μ§€μ†ν–ˆλ‹€. μ˜¬ν•΄ 법인세차감전계속사업손싀(법차손) 우렀λ₯Ό ν•΄μ†Œν•˜μ§€ λͺ»ν•˜λ©΄ 관리쒅λͺ©μ— 지정될 μœ„κΈ°μ— μ²˜ν–ˆλ‹€. λ‹€λ§Œ ν˜ˆμ•‘ 및 μ•” 진단 ν”Œλž«νΌ '마이랩'의 κΈ€λ‘œλ²Œ 곡급 ν™•λŒ€λ‘œ 맀좜 μ„±μž₯의 기틀을 닦은 점은 λˆˆμ— λˆλ‹€. μ˜¬ν•΄λΆ€ν„° μžκΆκ²½λΆ€μ•” 뢄석 μ†”λ£¨μ…˜ λ“± μ‹ μ œν’ˆμœΌλ‘œ μ„ μ§„μ‹œμž₯ κ³΅λž΅μ„ κ°•ν™”ν•˜λ©° 본격적인 싀적 μ„±μž₯을 κ΅¬κ°€ν•˜κ² λ‹¨ λͺ©ν‘œλ‹€. 노을은 μžκΆκ²½λΆ€μ„Έν¬λΆ„μ„ μ†”λ£¨μ…˜(마이랩 CER)κ³Ό ν˜ˆμ•‘λΆ„μ„(BCM) λ“± μ‹ μ œν’ˆ μ€‘μ‹¬μœΌλ‘œ 맀좜 ꡬ쑰λ₯Ό λ‹€λ³€ν™”ν•˜λŠ” 데 μ§‘μ€‘ν•˜κ³  μžˆλ‹€κ³  24일 λ°ν˜”λ‹€. 말라리아 진단 λΆ„μ•Όμ—μ„œ ν™•λ³΄ν•œ 경쟁λ ₯을 ν† λŒ€λ‘œ μ‹ μ œν’ˆμ˜ κΈ€λ‘œλ²Œ μ‹œμž₯ κ³΅λž΅μ„ κ°•ν™”ν•  κ³„νšμ΄λ‹€....

노을 맀좜 정보

λ‚ μ§œ λ§€μΆœμ•‘ λ§€μΆœμ•‘ μ¦κ°€μœ¨ μ˜μ—…μ΄μ΅ μ˜μ—…μ΄μ΅ μ¦κ°€μœ¨ 순이읡 순이읡 μ¦κ°€μœ¨
2025.4Q 5,121,885,655 219.83% -20,079,383,873 11.91% -19,954,848,715 11.19%
2024.4Q 1,601,464,029 -41.42% -22,794,691,591 -41.24% -22,469,262,527 -37.67%
2023.4Q 2,733,841,254 404.51% -16,138,745,065 -3.24% -16,321,080,150 -19.31%
2022.4Q 541,878,800 -63.27% -15,632,237,000 -36.67% -13,680,015,000 -11.10%

μˆœλ§€μˆ˜λŸ‰

개인: 22,577

κΈ°κ΄€: 0

외인: -31,277

λˆ„μ  μˆœλ§€μˆ˜λŸ‰

개인: 335,828

κΈ°κ΄€: -208,849

외인: -149,984

순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-05-06 22,577 - -31,277
2026-05-04 211,866 21 -211,888
2026-04-30 122,258 -418 -122,000
2026-04-29 48,607 271 -48,878
2026-04-28 77,272 -224 -86,137
2026-04-27 -413,023 61 412,930
2026-04-24 7,663 -1,317 -6,346
2026-04-23 61,738 -6 -61,815
2026-04-22 7,790 14 -11,384
2026-04-21 99,707 176 -100,603
2026-04-20 -8,003 45 7,958
2026-04-17 57,372 32 -57,982
2026-04-16 -40,119 23 40,084
2026-04-15 -88,684 49 88,620
2026-04-14 41,005 328 -38,667
2026-04-13 11,335 6 -14,007
2026-04-10 -97,134 29 97,103
2026-04-09 9,353 110 -9,463
2026-04-08 17,038 -8 -16,394
2026-04-07 5,043 -14 -5,659
2026-04-06 -41,239 -134 42,158

λˆ„μ  순맀수

λ‚ μ§œ 개인 κΈ°κ΄€ 외인
2026-05-06 112,422 -956 -133,647
2026-05-04 89,845 -956 -102,370
2026-04-30 -122,021 -977 109,518
2026-04-29 -244,279 -559 231,518
2026-04-28 -292,886 -830 280,396
2026-04-27 -370,158 -606 366,533
2026-04-24 42,865 -667 -46,397
2026-04-23 35,202 650 -40,051
2026-04-22 -26,536 656 21,764
2026-04-21 -34,326 642 33,148
2026-04-20 -134,033 466 133,751
2026-04-17 -126,030 421 125,793
2026-04-16 -183,402 389 183,775
2026-04-15 -143,283 366 143,691
2026-04-14 -54,599 317 55,071
2026-04-13 -95,604 -11 93,738
2026-04-10 -106,939 -17 107,745
2026-04-09 -9,805 -46 10,642
2026-04-08 -19,158 -156 20,105
2026-04-07 -36,196 -148 36,499
2026-04-06 -41,239 -134 42,158

노을 μžμ‚° λΉ„μœ¨

μžμ‚°μ΄κ³„ λΆ€μ±„λΉ„μœ¨ μžλ³ΈλΉ„μœ¨
39,224,540,809 34.53% 65.47%

노을 맀좜 ꡬ성

ꡬ성 μš”μ†Œ λΉ„μœ¨
μ•‘μ„Έμ„œλ¦¬ 및 κΈ°νƒ€μ„œλΉ„μŠ€ 67.89%
ν˜ˆμ•‘κ²€μ‚¬ 진단기기 [μ œν’ˆ] 27.13%
진단 μΉ΄νŠΈλ¦¬μ§€ [μ œν’ˆ] 4.98%

노을 곡맀도 ν˜„ν™©

졜근 곡맀도 κ±°λž˜λŸ‰: 16,649 (1.05%)

졜근 곡맀도 μž”κ³ : 117,400 (0.23%)

곡맀도 κ±°λž˜λŸ‰

λ‚ μ§œ μ’…κ°€ κ³΅λ§€λ„λŸ‰ 곡맀도비쀑
2026-05-06 1,373 16,649 1.05%
2026-05-04 1,460 26,252 2.57%
2026-04-30 1,548 12,188 1.59%
2026-04-29 1,654 0 0.00%
2026-04-28 1,682 0 0.00%
2026-04-27 1,728 76 0.01%
2026-04-24 1,685 7,388 3.49%
2026-04-23 1,689 8,403 3.44%
2026-04-22 1,703 6,194 2.88%
2026-04-21 1,707 13,743 3.72%
2026-04-20 1,756 0 0.00%
2026-04-17 1,739 11,599 4.05%
2026-04-16 1,741 12,997 2.07%
2026-04-15 1,711 5,910 1.58%
2026-04-14 1,668 20,221 6.10%
2026-04-13 1,657 21,861 4.32%
2026-04-10 1,632 4,815 1.94%
2026-04-09 1,570 5,402 2.25%
2026-04-08 1,583 9,971 5.10%
2026-04-07 1,567 16 0.01%
2026-04-06 1,577 1,103 0.42%

곡맀도 μž”κ³ 

λ‚ μ§œ μ’…κ°€ 곡맀도 μž”κ³  곡맀도 비쀑
2026-04-30 1,548 117,400 0.23%
2026-04-29 1,654 117,400 0.23%
2026-04-28 1,682 117,400 0.23%
2026-04-27 1,728 117,400 0.23%
2026-04-24 1,685 117,400 0.23%
2026-04-23 1,689 117,400 0.23%
2026-04-22 1,703 117,400 0.23%
2026-04-21 1,707 117,400 0.23%
2026-04-20 1,756 117,400 0.23%
2026-04-17 1,739 117,400 0.23%
2026-04-16 1,741 117,400 0.23%
2026-04-15 1,711 117,400 0.23%
2026-04-14 1,668 117,400 0.23%
2026-04-13 1,657 117,400 0.23%
2026-04-10 1,632 117,400 0.23%
2026-04-09 1,570 117,400 0.23%
2026-04-08 1,583 117,400 0.23%
2026-04-07 1,567 117,400 0.23%
2026-04-06 1,577 117,400 0.23%
2026-04-03 1,625 117,400 0.23%
2026-04-02 1,658 117,400 0.23%

노을 μ—…μ’… λ‚΄ 비ꡐ

의료μž₯λΉ„/μš©ν’ˆ μ—…μ’…(97개) μ—°κ°„ κΈ°μ€€

ν•­λͺ© 노을 μ—…μ’… 평균 μ—…μ’… λ‚΄ μˆœμœ„
μ‹œκ°€μ΄μ•‘ 748.853 3,408.54 66μœ„
PER(졜근4λΆ„κΈ°) -3.156 -46.3 56μœ„
PBR 2.916 6.8 25μœ„
ROE(졜근4λΆ„κΈ°) -87.044 -19.14 91μœ„
λ°°λ‹Ήμˆ˜μ΅λ₯ (μ΅œκ·Όμ—°λ„) - - -μœ„
μ˜μ—…μ΄μ΅λ₯ (μ΅œκ·Όμ—°λ„) -392.031 -89.66 93μœ„
순이읡λ₯ (μ΅œκ·Όμ—°λ„) -389.6 -139.01 92μœ„
λΆ€μ±„λΉ„μœ¨(μ΅œκ·Όμ—°λ„) 52.732 115.71 47μœ„
λ§€μΆœμ•‘(μ΅œκ·Όμ—°λ„) 51.219 836.24 87μœ„
μ˜μ—…μ΄μ΅(μ΅œκ·Όμ—°λ„) -200.794 10.6 89μœ„
λ‹ΉκΈ°μˆœμ΄μ΅(μ΅œκ·Όμ—°λ„) -199.548 -107.76 83μœ„